Business Terms
Angstrom Bio Raises $3M in Private Financing
The company is developing a nanopore sequencing-based test to simultaneously detect SARS-CoV-2 infection and identify variants of the virus.
Eagle Biosciences, Genetic Analysis Ink Distribution Agreement for Gut Microbiota Test
Under the agreement, Eagle Biosciences will distribute Genetic Analysis' GA-map Dysbiosis fecal gut microbiota test in North America.
Mologic Sues UK Government Over SARS-CoV-2 Antigen Test Validation
The diagnostic test developer said that the UK government's process for validating SARS-CoV-2 antigen tests is flawed and restricts the procurement of its test in the UK.
Centogene Q1 Revenues Grow More Than Fivefold Driven by COVID-19 Testing
Core diagnostic testing revenues were €6.4 million, down 15 percent year over year, while pharmaceutical revenues totaled €3.6 million, down 22 percent.
Epizyme Partnering With Quest Diagnostics for Lymphoma Mutation Testing
The companies have launched an initiative to improve patient access to EZH2Â mutation testing for patients with relapsed or refractory follicular lymphoma.